10.1 Medical Treatment & Medication History
Key Takeaways
- The medical history supplies the etiology for the nutrition diagnosis: diagnoses, GI surgeries, hospitalizations, birth history, immunizations, and developmental milestones each change nutrient needs or delivery.
- Chronic corticosteroids cause increased appetite and weight gain, hyperglycemia, calcium and bone loss, and linear growth suppression — monitor growth velocity and ensure calcium/vitamin D adequacy.
- Phenytoin binds enteral formula and loses absorption — hold tube feeds 1–2 hours before and after each dose and monitor drug levels.
- Grapefruit inhibits CYP3A4 and raises tacrolimus/cyclosporine levels; these immunosuppressants also cause hyperkalemia and magnesium wasting.
- ADHD stimulants suppress midday appetite — time calorie-dense meals and snacks around medication coverage and plot growth at least twice yearly.
Why the Medical History Drives the Nutrition Diagnosis
The medical treatment and medication history is the backbone of the clinical assessment in pediatric nutrition. Before estimating needs or writing a nutrition diagnosis, the specialist must understand why the child is in front of them: every diagnosis, surgery, hospitalization, and medication changes nutrient requirements, tolerance, or delivery. Within the nutrition care process, this history supplies the etiology of the nutrition diagnosis (the "related to" portion of the problem-etiology-signs/symptoms statement) and flags problems that intake data alone would never reveal.
Key elements to capture systematically:
- Diagnoses and comorbidities — acute and chronic conditions (cystic fibrosis, congenital heart disease, cerebral palsy, type 1 diabetes, inflammatory bowel disease, cancer) each carry predictable nutrition consequences: increased energy needs, malabsorption, feeding difficulty, or altered metabolism.
- Surgeries — gastrointestinal resections matter most. Loss of bowel length can produce short bowel syndrome, with malabsorption proportional to the segment removed; loss of the ileum impairs vitamin B12 and bile acid absorption; loss of the ileocecal valve raises small-bowel bacterial overgrowth risk. Fundoplication alters feeding tolerance and may require venting or slow-drip feeds.
- Hospitalizations — frequency and recency signal disease severity and control; intensive care stays and intubation history affect oral motor development and learned feeding skills.
- Birth history — gestational age, birth weight, and neonatal intensive care unit course are essential early in life. Prematurity changes everything: growth is plotted on corrected age until 24 months, nutrient needs (iron, calcium, phosphorus, vitamin D) are higher, and the history of human milk fortification or preterm formula matters.
- Immunization status — relevant for immunocompromised children (live vaccines are deferred during immunosuppression) and as a marker of preventive-care engagement.
- Developmental history — attainment of oral motor and feeding milestones (chewing, cup drinking, self-feeding) determines whether the diet is developmentally appropriate; developmental delay is a leading driver of pediatric feeding disorders.
High-Yield Pediatric Drug-Nutrient Interactions
| Medication/class | Nutrition effect | Specialist action |
|---|---|---|
| Corticosteroids (prednisone, prednisolone) | Increased appetite and weight gain, hyperglycemia, sodium retention, calcium loss with bone demineralization, linear growth suppression with chronic use | Monitor weight velocity and height; ensure calcium and vitamin D adequacy; counsel on appetite-driven intake |
| ADHD stimulants (methylphenidate, amphetamine salts) | Appetite suppression (peak at midday), slowed weight gain, possible small height effect | Time calorie-dense meals/snacks around medication coverage; monitor growth curves at least twice yearly |
| Valproate | Weight gain, insulin resistance | Monitor weight trajectory; support activity and intake counseling |
| Phenytoin, carbamazepine | Accelerated vitamin D metabolism (rickets/osteopenia risk), folate depletion | Check vitamin D status; supplement vitamin D/calcium; folate as indicated |
| Topiramate | Weight loss, anorexia, metabolic acidosis | Monitor weight and bicarbonate in at-risk children |
| Methotrexate | Folate antagonist — GI upset, mucositis | Folic acid supplementation per oncology/rheumatology protocol |
| Proton pump inhibitors (long-term) | Reduced absorption of vitamin B12, magnesium, and iron | Monitor with chronic use, especially with poor growth or anemia |
| Furosemide (loop diuretic) | Potassium, calcium, and magnesium losses | Monitor electrolytes; renal calcium wasting can cause nephrocalcinosis in preterm infants |
| Thiazide diuretics | Calcium retention (hypercalcemia risk), potassium loss | Distinct from loop diuretics — do not conflate |
| Tetracyclines, fluoroquinolones (older children) | Chelation with calcium/dairy and iron reduces drug absorption | Separate administration from dairy and minerals by about 2 hours |
| Isotretinoin | Hypertriglyceridemia, elevated lipids | Baseline and follow-up lipid monitoring |
| Orlistat | Fat malabsorption with fat-soluble vitamin loss (A, D, E, K) | Supplement fat-soluble vitamins; separate dosing from meals |
| Metformin | Vitamin B12 deficiency with long-term use | Periodic B12 monitoring in adolescents with type 2 diabetes or PCOS |
| Asparaginase (chemotherapy) | Hyperglycemia, hypertriglyceridemia, pancreatitis | Monitor glucose and triglycerides; adjust diet during pancreatic complications |
| Tacrolimus, cyclosporine | Grapefruit/grapefruit juice inhibits CYP3A4 and raises drug levels; hyperkalemia; magnesium wasting | Counsel families to avoid grapefruit; monitor potassium and magnesium |
Medication Administration With Feeds
Enteral feeding changes drug handling, and several interactions are exam favorites. The classic scenario is phenytoin and enteral formula: phenytoin binds to the feeding, reducing absorption and causing subtherapeutic levels and breakthrough seizures; feeds are typically held 1-2 hours before and after the dose, with drug-level monitoring and flushing around administration. Levothyroxine absorption is reduced by soy formula, iron, and calcium — dose on an empty stomach and separate from supplements. When giving medications through feeding tubes: do not crush enteric-coated or extended-release products, use liquid formulations when available, dilute hyperosmolar medications to reduce GI intolerance, and flush the tube before and after each medication to prevent clogging and in-line drug interactions.
Medical Devices and Treatments That Change Nutrition Care
Mechanical ventilation blunts oral feeding and changes energy prescription: critically ill, sedated, ventilated children often have lower-than-predicted energy needs early in the course, and overfeeding increases carbon dioxide production, which can delay ventilator weaning. Renal replacement therapy (hemodialysis, peritoneal dialysis) imposes fluid, sodium, potassium, and phosphorus restrictions while raising protein needs because of dialysate losses (cross-reference renal nutrition content). Oxygen dependence in bronchopulmonary dysplasia increases the work of breathing and raises energy needs. Extracorporeal therapies and suctioning schedules can interrupt feeds and must be accounted for in the feeding plan.
Reconciling Over-the-Counter and Herbal Products
Medication reconciliation is incomplete without asking directly about over-the-counter drugs, vitamins, and herbal or traditional remedies — families rarely volunteer them because they do not think of them as medications. Screen for interactions (for example, St. John's Wort induces CYP3A4 and can lower immunosuppressant levels), contamination and dose inaccuracy in supplements, and duplication of active ingredients across products. Document everything in the medical record so the whole team sees the complete picture before making changes.
A child on long-term phenytoin begins continuous enteral tube feedings, and seizure control worsens despite stable dosing. What is the most appropriate nutrition-related action?
Which set of nutrition effects is most characteristic of chronic systemic corticosteroid therapy in children?
A transplant recipient stabilized on tacrolimus should be counseled to avoid which food because it inhibits CYP3A4 and raises drug levels?